Porcilis APP inj. sol. i.m.
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Actinobacillus pleuropneumoniae RTX toxine III (ApxIII) 50 U/dose; Actinobacillus pleuropneumoniae RTX toxine I (ApxI) 50 U/dose; Actinobacillus pleuropneumoniae Outer Membrane Protein (OMP) 50 U/dose; Actinobacillus pleuropneumoniae RTX toxine II (ApxII) 50 U/dose
Available from:
Intervet International B.V.
ATC code:
QI09AB04
Pharmaceutical form:
Solution for injection
Administration route:
Intramuscular use
Therapeutic area:
Bordetella + Pasteurella
Product summary:
CTI Extended: 301043-02; 301043-01; 301043-04; 301043-03
Authorization status:
Commercialised: No
Authorization date:
2007-08-27
